Molecules, Vol. 26, Pages 2671: New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
Molecules, Vol. 26, Pages 2671: New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
Molecules doi: 10.3390/molecules26092671
Authors:
Marco Terreni
Marina Taccani
Massimo Pregnolato
The present work aims to examine the worrying problem of antibiotic resistance and the emergence of multidrug-resistant bacterial strains, which have now become really common in hospitals and risk hindering the global control of infectious diseases. After a careful examination of these phenomena and multiple mechanisms that make certain bacteria resistant to specific antibiotics that were originally effective in the treatment of infections caused by the same pathogens, possible strategies to stem antibiotic resistance are analyzed. This paper, therefore, focuses on the most promising new chemical compounds in the current pipeline active against multidrug-resistant organisms that are innovative compared to traditional antibiotics: Firstly, the main antibacterial agents in clinical development (Phase III) from 2017 to 2020 are listed (with special attention on the treatment of infections caused by the pathogens Neisseria gonorrhoeae, including multidrug-resistant isolates, and Clostridium difficile), and then the paper moves on to the new agents of pharmacological interest that have been approved during the same period. They include tetracycline derivatives (eravacycline), fourth generation fluoroquinolones (delafloxacin), new c...
Source: Molecules - Category: Chemistry Authors: Marco Terreni Marina Taccani Massimo Pregnolato Tags: Review Source Type: research
More News: Chemistry | Clostridium Difficile | Hospitals | Infectious Diseases | Men | Multidrug Resistance | Nanotechnology | Tetracycline